The position paper Recommendations for greener human medicines provides recommendations on how the sustainability of human medicinal products on the EU market and pharmaceutical supply chains can be improved.
The European Commission is set to propose the revised EU general pharmaceuticals legislation based on the Pharmaceutical Strategy for Europe in late 2022. This position paper includes 30 policy recommendations focused on three areas:
- Improving the transparency and sustainability of the pharmaceutical supply chain
- Strengthening environmental risk assessments for human medicine
- Encouraging greener medicines, promoting responsible use, and reducing pharmaceutical waste.